Lopid Tablet, Film Coated
Product Images NDC 0071-0737

3 FDA label images from Parke-davis Div Of Pfizer Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lopid (NDC 0071-0737). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Parke-davis Div Of Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Lopid 01)

Chemical Structure (Lopid 01)
Chemical structure of gemfibrozil, the active ingredient in Lopid (600 mg film-coated tablets). The structure shows a benzene ring substituted with methyl groups and an aliphatic chain ending with a carboxylic acid group.*
FDA Label Image

Logo (Lopid 02)

FDA Label Image

Principal Display Panel (600 mg Tablet Bottle Label)

Principal Display Panel (600 mg Tablet Bottle Label)
Lopid 600 mg film-coated tablets label showing gemfibrozil as the active ingredient. The label includes storage instructions at controlled room temperature (20° - 25°C), warnings to protect from light and humidity, and packaging in tight child-resistant containers. Manufactured by Parke-Davis Division of Pfizer Inc, this bottle contains 500 tablets labeled Rx only, made in India with NDC 0071-0737-30.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.